Item 8.01 Other Events.

On April 27, 2023, OncoSec Medical Incorporated (the "Company") posted an updated investor presentation on its website at www.oncosec.com. A copy of the presentation is filed herewith as Exhibit 99.1 and is incorporated by reference herein.

Additionally, on April 27, 2023, the Company issued a press release announcing funds received in connection with the sale of its net operating loss ("NOL") tax benefits through the New Jersey Economic Development Authority's NOL program. The full text of the press release is furnished as Exhibit 99.2 hereto and incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.





(d) Exhibits.

The following exhibits are filed herewith:

99.1 Investor Presentation of OncoSec Medical Incorporated dated April 27,

2023.


99.2   Press release dated April 27, 2023.
104  Cover Page Interactive Data File (embedded within the Inline XBRL document).

© Edgar Online, source Glimpses